United States Medullary Thyroid Cancer Drugs Market Report 2017

January 2017 | 97 pages | ID: U8F9E39519BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Medullary Thyroid Cancer Drugs

Revenue, means the sales value of Medullary Thyroid Cancer Drugs

This report studies sales (consumption) of Medullary Thyroid Cancer Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sinofi Genzyme
• Exelixis

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Caprelsa
• Cabozantinib

Split by applications, this report focuses on sales, market share and growth rate of Medullary Thyroid Cancer Drugs in each application, can be divided into

• Collection
• Packing
• Others

Contents

United States Medullary Thyroid Cancer Drugs Market Report 2017

1 MEDULLARY THYROID CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Medullary Thyroid Cancer Drugs
1.2 Classification of Medullary Thyroid Cancer Drugs
  1.2.1 Caprelsa
  1.2.2 Cabozantinib
1.3 Application of Medullary Thyroid Cancer Drugs
  1.3.1 Collection
  1.3.2 Packing
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Medullary Thyroid Cancer Drugs (2011-2021)
  1.4.1 United States Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES MEDULLARY THYROID CANCER DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Medullary Thyroid Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Medullary Thyroid Cancer Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Medullary Thyroid Cancer Drugs Average Price by Manufactures (2015 and 2016)
2.4 Medullary Thyroid Cancer Drugs Market Competitive Situation and Trends
  2.4.1 Medullary Thyroid Cancer Drugs Market Concentration Rate
  2.4.2 Medullary Thyroid Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MEDULLARY THYROID CANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Medullary Thyroid Cancer Drugs Sales and Market Share by States (2011-2016)
3.2 United States Medullary Thyroid Cancer Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Medullary Thyroid Cancer Drugs Price by States (2011-2016)

4 UNITED STATES MEDULLARY THYROID CANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Medullary Thyroid Cancer Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Medullary Thyroid Cancer Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Medullary Thyroid Cancer Drugs Price by Type (2011-2016)
4.4 United States Medullary Thyroid Cancer Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES MEDULLARY THYROID CANCER DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Medullary Thyroid Cancer Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Medullary Thyroid Cancer Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES MEDULLARY THYROID CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Sinofi Genzyme
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Medullary Thyroid Cancer Drugs Product Type, Application and Specification
    6.1.2.1 Caprelsa
    6.1.2.2 Cabozantinib
  6.1.3 Sinofi Genzyme Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Exelixis
  6.2.2 Medullary Thyroid Cancer Drugs Product Type, Application and Specification
    6.2.2.1 Caprelsa
    6.2.2.2 Cabozantinib
  6.2.3 Exelixis Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview

7 MEDULLARY THYROID CANCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Medullary Thyroid Cancer Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Medullary Thyroid Cancer Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Medullary Thyroid Cancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Medullary Thyroid Cancer Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MEDULLARY THYROID CANCER DRUGS MARKET FORECAST (2016-2021)

11.1 United States Medullary Thyroid Cancer Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Medullary Thyroid Cancer Drugs Sales Forecast by Type (2016-2021)
11.3 United States Medullary Thyroid Cancer Drugs Sales Forecast by Application (2016-2021)
11.4 Medullary Thyroid Cancer Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Medullary Thyroid Cancer Drugs
Table Classification of Medullary Thyroid Cancer Drugs
Figure United States Sales Market Share of Medullary Thyroid Cancer Drugs by Type in 2015
Figure Caprelsa Picture
Figure Cabozantinib Picture
Table Application of Medullary Thyroid Cancer Drugs
Figure United States Sales Market Share of Medullary Thyroid Cancer Drugs by Application in 2015
Figure Collection Examples
Figure Packing Examples
Figure Others Examples
Figure United States Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Medullary Thyroid Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Medullary Thyroid Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Medullary Thyroid Cancer Drugs Sales Share by Manufacturers
Figure 2016 Medullary Thyroid Cancer Drugs Sales Share by Manufacturers
Table United States Medullary Thyroid Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers
Table United States Market Medullary Thyroid Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Medullary Thyroid Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Medullary Thyroid Cancer Drugs Market Share of Top 3 Manufacturers
Figure Medullary Thyroid Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Medullary Thyroid Cancer Drugs Sales by States (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales Share by States (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Market Share by States in 2015
Table United States Medullary Thyroid Cancer Drugs Revenue and Market Share by States (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Medullary Thyroid Cancer Drugs by States (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Price by States (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales Share by Type (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Market Share by Type in 2015
Table United States Medullary Thyroid Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Medullary Thyroid Cancer Drugs by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Price by Type (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales Market Share by Application (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Market Share by Application in 2015
Table United States Medullary Thyroid Cancer Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Growth Rate by Application (2011-2016)
Table Sinofi Genzyme Basic Information List
Table Sinofi Genzyme Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sinofi Genzyme Medullary Thyroid Cancer Drugs Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Medullary Thyroid Cancer Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Medullary Thyroid Cancer Drugs
Figure Manufacturing Process Analysis of Medullary Thyroid Cancer Drugs
Figure Medullary Thyroid Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Medullary Thyroid Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Medullary Thyroid Cancer Drugs
Table Distributors/Traders List
Figure United States Medullary Thyroid Cancer Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Medullary Thyroid Cancer Drugs Production Forecast by Type (2016-2021)
Table United States Medullary Thyroid Cancer Drugs Consumption Forecast by Application (2016-2021)
Table United States Medullary Thyroid Cancer Drugs Sales Forecast by States (2016-2021)
Table United States Medullary Thyroid Cancer Drugs Sales Share Forecast by States (2016-2021)